Insmed (INSM) News Today $81.06 -2.55 (-3.05%) Closing price 04:00 PM EasternExtended Trading$81.36 +0.30 (+0.37%) As of 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Insmed price target lowered to $96 from $97 at StifelFebruary 22 at 12:07 AM | markets.businessinsider.comInsmed Full Year 2024 Earnings: EPS Misses ExpectationsFebruary 21 at 7:05 PM | finance.yahoo.comInsmed price target raised to $108 from $105 at TruistFebruary 21 at 7:05 PM | markets.businessinsider.comSara Bonstein Sells 18,322 Shares of Insmed Incorporated (NASDAQ:INSM) StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CFO Sara Bonstein sold 18,322 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $80.31, for a total value of $1,471,439.82. Following the sale, the chief financial officer now owns 118,863 shares of the company's stock, valued at $9,545,887.53. The trade was a 13.36 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.February 21 at 5:28 PM | marketbeat.comWilliam Lewis Sells 18,750 Shares of Insmed Incorporated (NASDAQ:INSM) StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 18,750 shares of Insmed stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $81.03, for a total transaction of $1,519,312.50. Following the completion of the transaction, the chief executive officer now directly owns 334,186 shares of the company's stock, valued at approximately $27,079,091.58. This trade represents a 5.31 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.February 21 at 5:28 PM | marketbeat.comInsmed (NASDAQ:INSM) Issues Quarterly Earnings ResultsInsmed (NASDAQ:INSM - Get Free Report) announced its earnings results on Thursday. The biopharmaceutical company reported ($1.32) earnings per share for the quarter, missing analysts' consensus estimates of ($1.17) by ($0.15).February 21 at 11:39 AM | marketbeat.comInsmed (NASDAQ:INSM) Shares Gap Down on Disappointing EarningsInsmed (NASDAQ:INSM) Shares Gap Down Following Weak EarningsFebruary 21 at 10:40 AM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) CFO Sells $1,471,439.82 in StockFebruary 21 at 6:33 AM | insidertrades.comInsmed Incorporated (NASDAQ:INSM) Position Increased by Rhumbline AdvisersRhumbline Advisers lifted its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 288,337 shares of the biopharmaceutical company's stock after acquiring an additional 25,292 shares duFebruary 21 at 3:32 AM | marketbeat.comInsmed (NASDAQ:INSM) Shares Gap Down Following Weak EarningsFebruary 21 at 2:59 AM | americanbankingnews.comInsmed targets $405M-$425M ARIKAYCE revenue for 2025 while advancing brensocatib and TPIP programsFebruary 20 at 11:59 PM | msn.comCantor Fitzgerald Reaffirms "Overweight" Rating for Insmed (NASDAQ:INSM)Cantor Fitzgerald restated an "overweight" rating on shares of Insmed in a research note on Wednesday.February 20 at 10:18 AM | marketbeat.comInsmed (NASDAQ:INSM) Stock Price Expected to Rise, Wells Fargo & Company Analyst SaysWells Fargo & Company raised their price objective on Insmed from $85.00 to $107.00 and gave the company an "overweight" rating in a report on Wednesday.February 20 at 9:13 AM | marketbeat.comInsmed reports Q4 EPS ($1.32), consensus ($1.16)February 20 at 8:54 AM | markets.businessinsider.comInsmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business UpdateFebruary 20 at 7:00 AM | prnewswire.comState of New Jersey Common Pension Fund D Buys 4,438 Shares of Insmed Incorporated (NASDAQ:INSM)State of New Jersey Common Pension Fund D boosted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 64,061 sharFebruary 20 at 3:53 AM | marketbeat.comInsmed (INSM) to Release Earnings on ThursdayInsmed (NASDAQ:INSM) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=664316)February 20 at 1:59 AM | marketbeat.comInsmed (NASDAQ:INSM) Hits New 52-Week High - Should You Buy?Insmed (NASDAQ:INSM) Hits New 52-Week High - Should You Buy?February 19 at 9:12 PM | marketbeat.comWill Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?February 19 at 10:50 AM | insidermonkey.comTimesSquare Capital Management LLC Grows Position in Insmed Incorporated (NASDAQ:INSM)TimesSquare Capital Management LLC lifted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 41.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 684,384 shares of the biopharmaceutical company's stock after buying an addFebruary 19 at 6:37 AM | marketbeat.comPrincipal Financial Group Inc. Has $125.49 Million Position in Insmed Incorporated (NASDAQ:INSM)Principal Financial Group Inc. decreased its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 2.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,817,643 shares of the biopharmaceutical company's stFebruary 19 at 4:39 AM | marketbeat.comMizuho Securities Sticks to Its Buy Rating for Insmed (INSM)February 19 at 12:54 AM | markets.businessinsider.comRice Hall James & Associates LLC Sells 4,632 Shares of Insmed Incorporated (NASDAQ:INSM)Rice Hall James & Associates LLC cut its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 88,860 shares of the biopharmaceutical companyFebruary 18 at 6:49 AM | marketbeat.comPeregrine Capital Management LLC Acquires 20,642 Shares of Insmed Incorporated (NASDAQ:INSM)Peregrine Capital Management LLC lifted its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 11.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 193,479 shares of the biopharmaceutical company's stockFebruary 18 at 6:14 AM | marketbeat.comVan ECK Associates Corp Sells 7,790 Shares of Insmed Incorporated (NASDAQ:INSM)Van ECK Associates Corp reduced its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 6.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 119,234 shares of the biopharmaceutical company's stock after sFebruary 17, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Purchases 32,960 Shares of Insmed Incorporated (NASDAQ:INSM)Allspring Global Investments Holdings LLC lifted its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 8.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 423,094 shares of the biopharmaceutical company's stock afFebruary 16, 2025 | marketbeat.comInsmed (NASDAQ:INSM) versus Shuttle Pharmaceuticals (NASDAQ:SHPH) Head to Head ComparisonFebruary 15, 2025 | americanbankingnews.comInsmed Incorporated (NASDAQ:INSM) CFO Sara Bonstein Sells 13,302 SharesInsmed Incorporated (NASDAQ:INSM - Get Free Report) CFO Sara Bonstein sold 13,302 shares of the business's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $80.00, for a total value of $1,064,160.00. Following the sale, the chief financial officer now owns 142,204 shares of the company's stock, valued at approximately $11,376,320. This trade represents a 8.55 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.February 14, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) CFO Sells $1,064,160.00 in StockFebruary 14, 2025 | insidertrades.comFiera Capital Corp Sells 10,561 Shares of Insmed Incorporated (NASDAQ:INSM)Fiera Capital Corp lessened its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 1.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 581,854 shares of the biopharmaceutical company's stock after seFebruary 14, 2025 | marketbeat.comInsider Selling: Insmed Incorporated (NASDAQ:INSM) Insider Sells 37,828 Shares of StockFebruary 13, 2025 | insidertrades.comInsmed (NASDAQ:INSM) Stock Price Expected to Rise, Stifel Nicolaus Analyst SaysFebruary 13, 2025 | americanbankingnews.comMartina M.D. Flammer Sells 37,828 Shares of Insmed Incorporated (NASDAQ:INSM) StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) insider Martina M.D. Flammer sold 37,828 shares of the business's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $78.61, for a total value of $2,973,659.08. Following the completion of the sale, the insider now directly owns 100,165 shares in the company, valued at $7,873,970.65. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.February 12, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) COO Sells $3,378,264.75 in StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) COO Roger Adsett sold 42,975 shares of Insmed stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $78.61, for a total transaction of $3,378,264.75. Following the completion of the transaction, the chief operating officer now directly owns 146,082 shares of the company's stock, valued at $11,483,506.02. This trade represents a 22.73 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.February 12, 2025 | marketbeat.comInsmed COO Roger Adsett sells $3.38 million in stockFebruary 12, 2025 | msn.comInsmed's chief medical officer sells $2.97 million in stockFebruary 12, 2025 | msn.comInsmed (NASDAQ:INSM) Price Target Raised to $97.00 at Stifel NicolausStifel Nicolaus increased their price target on Insmed from $88.00 to $97.00 and gave the company a "buy" rating in a research report on Tuesday.February 11, 2025 | marketbeat.comStifel Nicolaus Remains a Buy on Insmed (INSM)February 11, 2025 | markets.businessinsider.comStifel raises Insmed stock target to $97, maintains Buy ratingFebruary 11, 2025 | msn.comInsmed price target raised to $97 from $88 at StifelFebruary 11, 2025 | markets.businessinsider.comInsmed To Present at March 2025 Investor ConferencesFebruary 11, 2025 | prnewswire.comInsmed (NASDAQ:INSM) Trading Down 4% on Insider SellingFebruary 11, 2025 | americanbankingnews.comInsmed (NASDAQ:INSM) Shares Down 4% on Insider SellingInsmed (NASDAQ:INSM) Shares Down 4% Following Insider SellingFebruary 10, 2025 | marketbeat.comEvercore ISI Sticks to Their Buy Rating for Insmed (INSM)February 10, 2025 | markets.businessinsider.comInsmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025February 10, 2025 | prnewswire.comWCM Investment Management LLC Sells 3,590 Shares of Insmed Incorporated (NASDAQ:INSM)WCM Investment Management LLC reduced its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 144,740 shares of the biopharmaceutical company's stock aFebruary 10, 2025 | marketbeat.comFinancial Advocates Investment Management Buys Shares of 4,846 Insmed Incorporated (NASDAQ:INSM)Financial Advocates Investment Management purchased a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 4,846 shares of the biopharmaceutical company's stocFebruary 10, 2025 | marketbeat.comInsmed's chief commercial officer sells $640,708 in stockFebruary 9, 2025 | investing.comInsmed's COO Roger Adsett sells $3.7 million in stockFebruary 8, 2025 | msn.comInsmed CFO Sara Bonstein sells $2.3 million in company stockFebruary 8, 2025 | msn.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼0.600.60▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼3610▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Royalty Pharma News Today Teva Pharmaceutical Industries News Today United Therapeutics News Today Summit Therapeutics News Today Genmab A/S News Today Intra-Cellular Therapies News Today Viatris News Today BioMarin Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersHere’s how you could profit from Elon’s NVIDIA partnership"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerfu...Behind the Markets | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INSM Stock Alerts